NOCIL reports Rs 27.76 cr profit; Rs 250 cr plant enters trial production
Operating profit of Rs 45.22 cr was reduced by Rs 13.73 cr depreciation, while management said trial-plant samples were sent for approval.
Filed 03 Aug 2026, 14:21 IST · NOCIL (NOCIL)
Key takeaways
- NOCIL's consolidated Q1FY27 operating profit of Rs 45.22 cr was the key earnings anchor, with depreciation of Rs 13.73 cr taking profit before tax to Rs 37.09 cr.
- Other income of Rs 5.9 cr was secondary to operating earnings, while the 25.16% tax rate resulted in net profit of Rs 27.76 cr.
- Management said the Rs 250 cr capex programme has reached trial production, with samples sent for approval.
Operating profit leads the Q1FY27 earnings bridge
NOCIL reported consolidated revenue of Rs 403.02 cr and operating profit of Rs 45.22 cr in Q1FY27. Depreciation was the main drag below operating profit at Rs 13.73 cr, compared with Rs 0.3 cr of interest, while Rs 5.9 cr of other income partly offset those costs. Operating earnings therefore mattered more than non-operating income in assessing the quarter.
The Rs 250 cr expansion has reached trial production
Management said NOCIL's Rs 250 cr capex programme has moved into trial production and that samples have been sent for approval. The company also said global sourcing is expected to shift towards a China + 1 model. Management described its export strategy as aimed at reducing reliance on the Chinese market.
Sourcing strategy remains central to the business narrative
Management said NOCIL is positioning itself as a key global rubber-chemical player through product quality, service offerings and exports. The China + 1 comment links the sourcing opportunity to the company's stated effort to reduce dependence on the Chinese market, while the trial-production update marks a separate expansion milestone.
Q1FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹403 cr |
| Other income | ₹6 cr |
| Expenses | ₹358 cr |
| Operating profit | ₹45 cr |
| Operating margin (%) | 11.22% |
| Interest | ₹0 cr |
| Depreciation | ₹14 cr |
| Profit before tax | ₹37 cr |
| Tax | ₹9 cr |
| Net profit | ₹28 cr |
| EPS (₹) | ₹1.66 |
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
Guidance & outlook
- Global sourcing is expected to shift toward a China + 1 model.
Expansion
- NOCIL announced a ₹250 crore capex programme, and the plant has entered trial production with samples sent for approval.
New initiatives
- NOCIL partnered with NM Sadguru under NABARD’s Tribal Development Fund Wadi Programme for tribal farmers.
Competition
- NOCIL describes itself as a key global rubber-chemical player with a strategy to reduce reliance on the Chinese market.
What to watch
- Whether the trial-production plant linked to the Rs 250 cr capex programme receives approval for its samples.
- Whether operating profit remains above Rs 45.22 cr in the next reported quarter.
- Whether other income stays near Rs 5.9 cr without becoming a larger part of reported earnings.